FindTrial
Sign In

The outcome of Siewert type II/III esophagogastric junctional adenocarcinoma patients receiving total gastrectomy: laparoscopic versus robot-assisted gastrectomy

The outcome of Siewert type II/III esophagogastric junctional adenocarcinoma patients receiving total gastrectomy: laparoscopic versus robot-assisted gastrectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-13003301
Enrollment
Unknown
Registered
2013-07-01
Start date
2013-07-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

esophagogastric junctional adenocarcinoma

Interventions

robot group:robot surgery
lap group:laparoscopic surgery

Sponsors

Xijing hospital, Fourth Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients with Siewert type II/III esophagogastric junctional adenocarcinoma (Age from 18 to 75); 2. No chemotherapy or radiotherapy was performed before operation3understood the experiment, informed consent.

Exclusion criteria

Exclusion criteria: 1. operative contraindication; 2. patients with metastatic disease.

Design outcomes

Primary

MeasureTime frame
Anastomotic leak;—

Secondary

MeasureTime frame
Pulmonary infection;Anastomotic stricture;Wound infection;—

Countries

China

Contacts

Public ContactLiu Hong
hongliu180@126.com+86 13709284513

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026